ecc4703
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 16, 2022 (NCT05552274)
Timeline
Indications
Mechanism of action
THRB agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07288138 | Phase 2 | Dec 15, 2025 | Eccogene Clinical Trials |
| NCT05552274 | Early Phase 1 (Phase 1) | Aug 16, 2022 | Eccogene Clinical Trials |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eccogene Clinical Trials | For profit | 2 | 2 | 2 | 2022 |
1 organizations
Page 1 / 1